File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Effects of cimetidine, ranitidine, and antacid on renal function

TitleEffects of cimetidine, ranitidine, and antacid on renal function
Authors
Yeung, CKWong, KLNg, MTLai, CL
Issue Date1984
PublisherExcerpta Medica, Inc. The Journal's web site is located at http://www.elsevier.com/locate/clinthera
Citation
Clinical Therapeutics, 1984, v. 6 n. 5, p. 620-624 How to Cite?
AbstractSerum creatinine and beta2-microglobulin levels, endogenous creatinine clearance, the urinary beta2-microglobulin excretion rate, and urinary protein levels were monitored serially in 29 patients with duodenal ulcers randomly allocated to receive eight weeks of treatment with cimetidine, ranitidine, or an antacid. A clinically insignificant increase in endogenous creatinine clearance was noted in patients given ranitidine. No adverse change in any of the variables measured was detected in any group of patients during the 12-week period of study.
Persistent Identifierhttp://hdl.handle.net/10722/161676
ISSN
0149-2918
2023 Impact Factor: 3.2
2023 SCImago Journal Rankings: 0.875
ISI Accession Number ID
WOS:A1984TG72600008

 

DC FieldValueLanguage
dc.contributor.authorYeung, CKen_US
dc.contributor.authorWong, KLen_US
dc.contributor.authorNg, MTen_US
dc.contributor.authorLai, CLen_US
dc.date.accessioned2012-09-05T05:13:46Z-
dc.date.available2012-09-05T05:13:46Z-
dc.date.issued1984en_US
dc.identifier.citationClinical Therapeutics, 1984, v. 6 n. 5, p. 620-624en_US
dc.identifier.issn0149-2918en_US
dc.identifier.urihttp://hdl.handle.net/10722/161676-
dc.description.abstractSerum creatinine and beta2-microglobulin levels, endogenous creatinine clearance, the urinary beta2-microglobulin excretion rate, and urinary protein levels were monitored serially in 29 patients with duodenal ulcers randomly allocated to receive eight weeks of treatment with cimetidine, ranitidine, or an antacid. A clinically insignificant increase in endogenous creatinine clearance was noted in patients given ranitidine. No adverse change in any of the variables measured was detected in any group of patients during the 12-week period of study.en_US
dc.languageengen_US
dc.publisherExcerpta Medica, Inc. The Journal's web site is located at http://www.elsevier.com/locate/clintheraen_US
dc.relation.ispartofClinical Therapeuticsen_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshAntacids - Therapeutic Useen_US
dc.subject.meshCimetidine - Therapeutic Useen_US
dc.subject.meshCreatinine - Analysisen_US
dc.subject.meshDuodenal Ulcer - Drug Therapy - Physiopathologyen_US
dc.subject.meshHumansen_US
dc.subject.meshKidney - Drug Effects - Physiopathologyen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshRandom Allocationen_US
dc.subject.meshRanitidine - Therapeutic Useen_US
dc.subject.meshTime Factorsen_US
dc.subject.meshBeta 2-Microglobulin - Analysisen_US
dc.titleEffects of cimetidine, ranitidine, and antacid on renal functionen_US
dc.typeArticleen_US
dc.identifier.emailLai, CL:hrmelcl@hku.hken_US
dc.identifier.authorityLai, CL=rp00314en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.pmid6090020-
dc.identifier.scopuseid_2-s2.0-0021262743en_US
dc.identifier.volume6en_US
dc.identifier.issue5en_US
dc.identifier.spage620en_US
dc.identifier.epage624en_US
dc.identifier.isiWOS:A1984TG72600008-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridYeung, CK=7201354123en_US
dc.identifier.scopusauthoridWong, KL=7404759833en_US
dc.identifier.scopusauthoridNg, MT=7202076422en_US
dc.identifier.scopusauthoridLai, CL=7403086396en_US
dc.identifier.issnl0149-2918-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats